Bursky Annual Symposium

Each year the Bursky Center hosts an annual symposium which profiles advances in the field of human immunology.

On Thursday, February 2, 2017, the inaugural symposium "Advances and Opportunities in Human Immunology and Immunotherapy," was held at the Eric P. Newman Education Center on the Washington University School of Medicine campus.  The Bursky Center at Washington University Inaugural Symposium featured distinguished scientists and profiled remarkable advances in the development of treatment options for cancer, infectious diseases, autoimmune disorders, and brain tumors.  The following list highlights featured talks:

"Advances in Personalized Cancer Immunotherapy"
Robert D. Schreiber, PhD
Andrew M. and Jane M. Bursky Distinguished Professor
Director, Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs

"New Insights into Human Diseases Caused by Immune System Dysfunction"
Wayne M. Yokoyama, MD
Sam J. Levin and Audrey Lowe Levin Professor of Arthritis Research
Associate Director, Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs

"Discoveries in Basic Biology of Infectious Diseases and Their Rapid Transition to Drug and Vaccine"
Michael S. Diamond, MD, PhD
Herbert S. Gasser Professor
Associate Director, Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs

"Innovation, Crisis and the Role of Biotechnology"
Robert I. Tepper, MD
Partner and Co-Founder, Third Rock Ventures, LLC

"Building Better Medicines: The Role of the Biopharmaceutical Industry"
Roger M. Perlmutter, MD, PhD
Executive Vice President, Merck & Co.
President, Merck Research Laboratories